[Company Performance]: QDI.BE's stock price heavily relies on its financial health, including revenue, profit margins, and debt levels. Strong earnings reports typically drive the price up, while losses can cause it to decline.

[Industry Trends]: The overall performance of the biotechnology sector influences QDI.BE. Positive industry growth, technological advancements, or increasing demand for biotech products can boost investor confidence.

[Market Sentiment]: Investor psychology, including fear and greed, can sway QDI.BE's price. Positive news about the economy or the company creates optimism, while negative news sparks selling pressure.

[Regulatory Environment]: Changes in regulations related to pharmaceuticals, biotechnology, or healthcare can have a significant impact. Favorable regulations can improve the outlook, while stricter rules can hinder growth.

[Economic Conditions]: Macroeconomic factors like interest rates, inflation, and unemployment can affect QDI.BE. Higher interest rates may make it more expensive for the company to borrow money, while a strong economy can boost consumer spending.

[Competition]: The competitive landscape within the biotech industry plays a role. The emergence of new competitors or the success of existing ones can impact QDI.BE's market share and, consequently, its stock price.

[Research & Development]: QDI.BE's pipeline of new drugs or therapies is critical. Positive clinical trial results or regulatory approvals for new products can trigger significant price increases.

[Mergers & Acquisitions]: News of potential mergers, acquisitions, or partnerships involving QDI.BE can cause substantial price fluctuations. A takeover bid often leads to a price surge, while a failed deal may cause a decline.